Intriguingly, besides AML-related ZM fusion, aberrant chromosomal rearrangements detected in endometrial stromal sarcoma patients recurrently target components of NuA4/TIP60 complex such as EP400, EPC1, EPC2, MEAF6 and MBTD146–50. This evidence concerns the gene KAT5 and endometrioid stromal sarcoma.